🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Live from #ENDO2025 The ability to create your own schedule on the app, that you can screenshot and share, sure makes ENDO life easier!

From #ENDO2025 Making Strides in Rare Bone Disease: Craniosynostosis affects 22% of children with XLH vs 0.05% of the general population

Type 1 Diabetes Barbie has made her scientific debut.Endocrine Society #Barbie #ENDO2025

Live from #ENDO2025 Bone & Mineral SIG Presents: EndoForum Case Review – Osteonecrosis of the Jaw, Atypical Femoral Fractures, and Hypoparathyroidism taking place now in the ENDOExpo is a packed house!

Live from #ENDO2025 Bone & Mineral SIG Presents: Osteonecrosis of the Jaw, Atypical Femoral Fractures, and Hypoparathyroidism is a great opportunity for attendees to share their own procedures in treating patients with unusual bone maladies. Great crowd!

Live from #ENDO2025 Bone & Mineral SIG Presents is an interactive discussion includes cases on: • Bisphosphonates and Dental Procedures • Osteoporosis Management in a Patient with Bilateral Atypical Femoral Fractures • PTH analogs for Severe Post-Surgical Hypoparathyroidism

Live from #ENDO2025 The Endocrine Society Bone & Mineral SIG's event at the ENDOExpo is drawing a HUGE crowd!

Our residents and alumni are kicking off day 1 of #ENDO2025!

Live from #ENDO2025 The Management of Cystic Fibrosis Related Diabetes (CFRD) "CGM measures can distinguish people with and without CFRD." - Melissa Pullman, MD

Co-chairs of Endocrine Society TCDCC, Matthew Sikora, PhD, and Inga Harbuz-Miller, MD, actively recruiting the next generation of endocrinologists at #ENDO2025

Whether you're presenting a 90-minute session, an oral abstract, or presenting your first poster at Endocrine Society's #ENDO2025 , be sure to let Endocrine News about your research!

Live from #ENDO2025 The Management of Cystic Fibrosis Related Diabetes (CFRD) take home points: CFRD is common and is associated with decline in pulmonary function, compromised nutritional status and mortality

Live from #ENDO2025 The Management of Cystic Fibrosis Related Diabetes (CFRD) take home point: The recommended screening test for CFRD is the OGTT but new alternative like CGM are being studied

Live from #ENDO2025 The Management of Cystic Fibrosis Related Diabetes (CFRD) #insulin is the only recommended treatment and has been shown to improve clinical status

Live from #ENDO2025 The Management of Cystic Fibrosis Related Diabetes (CFRD) take home points: #diabetes technology may help to improve glycemic management and reduce treatment burden

Live from #ENDO2025 The Management of Cystic Fibrosis Related Diabetes (CFRD) take home points: Rising rates of #obesity and metabolic syndrome raise the possibility for other treatment options -- GLP1 agonists, SGLT2 inhibitors, etc. for CFRD

Live from #ENDO2025 - Business of Medicine This session is designed for fellows and post-fellowship practicing endocrinologists interested in the business component of medicine. This panel discussion will provide insight from experienced industry professionals.

Live from #ENDO2025 Business of Medicine When asked what their top endocrinology career priority is, attendees said flexibility is 31% and income is 29%